Skip to main navigation Skip to search Skip to main content

Pathogenic XPO1 variants cause a dominant neurodevelopmental disorder

  • Amber S.E. van Oirsouw
  • , Pavla Nedbalova
  • , Miroslava Hancarova
  • , Jan Prchal
  • , Darina Prchalova
  • , Marketa Vlckova
  • , Sarka Bendova
  • , Kristin G. Monaghan
  • , Lisa M. Dyer
  • , Yanmin Chen
  • , Deanna Alexis Carere
  • , Emma A.M. te Bogt
  • , Heather Fisher
  • , Angela E. Scheuerle
  • , Stephanie Riley
  • , Mahim Jain
  • , Weiyi Mu
  • , Joann N. Bodurtha
  • , Albertien M. van Eerde
  • , Marijn F. Stokman
  • Nicola Longo, Meena Balasubramanian, Michael Spiller, Gregory Costain, Charlotte von der Lippe, Kristian Tveten, Marianne Jortveit, Øystein L. Holla, Bertrand Isidor, Benjamin Cogné, Kevin E. Glinton, Blake Vuocolo, Roberta Ann Sierra, Brad Angle, Kelly Bontempo, Klaas Koop, Rachel Rabin, John Pappas, David A. Staffenberg, Pascal Joset, Peter Miny, Isabel Filges, Abdulrazak Alali, Kara Vitalone, Jill A. Rosenfeld, Weimin Bi, Samuel Bradbrook, Renee Perrier, Subhadra Ramanathan, June Anne Gold, María Palomares Bralo, María Ángeles Gómez-Cano, Ann Haskins Olney, Shelly Nielsen, Alban Ziegler, Dominique Bonneau, Clément Prouteau, Ange Line Bruel, Charlotte Caille-Benigni, Laëtitia Lambert, Andrea C. Yu, Nathaniel H. Robin, Dana Goodloe, Jan Fischer, Joseph Porrmann, Yvonne D. Hennig, Rami Abou Jamra, Isabella Herman, Ivy R. Johnson, Lucas Hérissant, Guillaume Jouret, Koen L.I. van Gassen, Ellen van Binsbergen, Bert van der Zwaag, Alwin Kamermans, Renske Oegema, Zdenek Sedlacek, Michaela Fenckova, Richard H. van Jaarsveld
  • Utrecht University
  • University of South Bohemia
  • Charles University
  • University of Chemistry and Technology, Prague
  • OPKO Health, Inc.
  • University of Texas Southwestern Medical Center
  • Kennedy Krieger Institute
  • Department of Neurology and Developmental Medicine
  • Johns Hopkins University
  • Radboud University Nijmegen
  • University of California at Los Angeles
  • University of Sheffield
  • Sheffield Children's NHS Foundation Trust
  • University of Toronto
  • Telemark Hospital
  • Sørlandet Hospital
  • L'institut du Thorax
  • CHU de Nantes
  • Baylor College of Medicine
  • Advocate Children's Hospital
  • New York University
  • University of Basel
  • West Virginia University
  • Akron Children's Hospital
  • Alberta Children's Hospital
  • University of Calgary
  • Loma Linda University Health
  • University of California at Irvine
  • Hospital Universitario La Paz
  • ITHACA-European Reference Network
  • University of Nebraska Medical Center
  • Université d'Angers
  • Université de Bourgogne
  • Institut national de la santé et de la recherche médicale
  • CH Troyes
  • Université de Lorraine
  • University of Ottawa
  • University of Alabama at Birmingham
  • Technische Universität Dresden
  • Leipzig University
  • Boystown National Research Hospital
  • Laboratoire National de Santé

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Purpose: XPO1 functions in key cellular processes, including nucleo-cytoplasmic export and mitosis. The gene is deleted in a subset of patients with the 2p15p16.1 microdeletion syndrome; however, no monogenic XPO1-related disorder has been described to date. Methods: We collected clinical data of individuals with de novo XPO1 variants through online matchmaking. We used Drosophila to study XPO1 function in development and habituation learning. Results: A total of 22 individuals met the criteria to be included in the main study cohort. Of these, half have putative loss-of-function variants, and half have coding variants (10 missense and 1 in-frame deletion variant). We found an overlapping phenotype, consistent with a monogenic neurodevelopmental disorder. We demonstrate XPO1 functions in development by ubiquitous and neuron-specific knockdown in Drosophila. GABAergic neuron specific knockdown flies demonstrated impaired habituation. Conclusion: Our results establish XPO1 as a novel dominant monogenic neurodevelopmental disorder gene and demonstrate a central role for XPO1 in development.

Original languageEnglish
Article number101555
Pages (from-to)101555
JournalGenetics in Medicine
Volume27
Issue number11
Early online date13 Aug 2025
DOIs
StatePublished - Nov 2025
Externally publishedYes

Keywords

  • Dominant inheritance
  • Habituation
  • Mendelian disorders
  • Monogenic NDD
  • XPO1

Fingerprint

Dive into the research topics of 'Pathogenic XPO1 variants cause a dominant neurodevelopmental disorder'. Together they form a unique fingerprint.

Cite this